Let’s start up with the current stock price of Bionano Genomics Inc. (BNGO), which is $5.40 to be very precise. The Stock rose vividly during the last session to $5.58 after opening rate of $5.269 while the lowest price it went was recorded $4.99 before closing at $4.41.
Recently in News on May 13, 2021, Bionano Genomics Reports First Quarter 2021 Financial Results and Highlights Recent Business Progress. 179% year-over-year revenue increase driven by record sales of consumables and growth in the Saphyr installed base. You can read further details here
Bionano Genomics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $15.69 on 02/16/21, with the lowest value was $3.91 for the same time period, recorded on 01/08/21.
Bionano Genomics Inc. (BNGO) full year performance was 1250.34%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Bionano Genomics Inc. shares are logging -65.58% during the 52-week period from high price, and 1451.72% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.35 and $15.69.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 103453128 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Bionano Genomics Inc. (BNGO) recorded performance in the market was 75.32%, having the revenues showcasing -60.58% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.23B, as it employees total of 147 workers.
Market experts do have their say about Bionano Genomics Inc. (BNGO)
During the last month, 0 analysts gave the Bionano Genomics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 7.77, with a change in the price was noted +4.86. In a similar fashion, Bionano Genomics Inc. posted a movement of +900.00% for the period of last 100 days, recording 66,758,156 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BNGO is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.04.
Technical breakdown of Bionano Genomics Inc. (BNGO)
Raw Stochastic average of Bionano Genomics Inc. in the period of last 50 days is set at 19.89%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 32.09%. In the last 20 days, the company’s Stochastic %K was 14.62% and its Stochastic %D was recorded 11.94%.
Bearing in mind the latest performance of Bionano Genomics Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 75.32%. Additionally, trading for the stock in the period of the last six months notably improved by 864.46%, alongside a boost of 1250.34% for the period of the last 12 months. The shares increased approximately by -0.18% in the 7-day charts and went up by -11.62% in the period of the last 30 days. Common stock shares were lifted by -60.58% during last recorded quarter.